Key Takeaways
- Kenvue (KVUE) shares plummeted by as much as 16% today after a Wall Street Journal report indicated that U.S. Health Secretary Robert F. Kennedy Jr. plans to release a government report linking Tylenol (acetaminophen) use during pregnancy to autism.
- Russia's United Aircraft Corporation (UAC) has patented a new wide-body aircraft designed to directly compete with the Boeing (BA) 787 Dreamliner, a strategic move to bolster self-reliance amid Western sanctions.
- LiveSquawk's latest "Commodity Corner" teaser highlighted potential downside pressure on oil, diverging corn and soybean prices, and concerns about the stock market being "top-heavy", with the S&P 500 (SPX) on pace for its first weekly loss in a month.
Kenvue Shares Hit One-Year Low on Tylenol-Autism Report
Shares of Kenvue Inc. (KVUE), the consumer health company behind popular brands like Tylenol, experienced a sharp decline today, falling by as much as 16% and reaching a one-year low. The sell-off was triggered by a Wall Street Journal report suggesting that U.S. Health Secretary Robert F. Kennedy Jr. is set to release a government report linking the use of Tylenol (acetaminophen) during pregnancy to autism.
The anticipated report, expected this month, may also propose that a folate-derived medication could be effective in treating autism symptoms in some individuals. In response to the WSJ report, Kenvue stated that it continues to believe there is no causal link between acetaminophen use during pregnancy and autism. Kenvue, with a market capitalization of approximately $34.7 billion, was spun off from Johnson & Johnson (JNJ) in May 2023 and holds a significant position in the consumer health market.
Russia Advances Homegrown Wide-Body Aircraft Development
In a move aimed at reducing its reliance on foreign aviation, Russia's United Aircraft Corporation (UAC) has patented a new family of wide-body aircraft designed to rival the Boeing (BA) 787 Dreamliner and Airbus (AIR.PA) A350. This initiative, known as the ShFDMS program, includes three variants: the WBLRA-500, WBLRA-600, and WBLRA-700, with seating capacities ranging from 236 to 320 passengers. The WBLRA-600, positioned as a direct competitor to the Boeing 787-9, is projected by Russian sources to offer 3% lower ownership costs and 6% lower direct operating costs, with up to 17% lower costs per seat-kilometer.
This strategic development comes as Russia's aviation sector faces severe challenges due to Western sanctions imposed after the invasion of Ukraine, which have restricted access to crucial foreign-made aircraft and components. While early research and development projects are slated to begin in 2026, the ambitious undertaking faces significant hurdles, including securing modern engines, avionics, and materials under ongoing sanctions. The project also follows the scaling back of the joint CR929 wide-body venture with China, underscoring Moscow's renewed focus on domestic aviation self-reliance.
LiveSquawk Teases Commodity and Market Insights
LiveSquawk's "Commodity Corner Teaser" provided a snapshot of upcoming market analysis, highlighting several key areas of interest for traders. Analyst Chris Stadele discussed the potential for further downside pressure in crude oil markets and noted a recent divergence in corn and soybean prices as the growing season concludes. The teaser also touched upon recent developments in the aluminum market.
Beyond commodities, the analysis indicated a broader concern for equity markets, with the S&P 500 (SPX) currently on pace for its first weekly loss in approximately a month. The report suggested that the stock market is becoming "top-heavy" and that "frothiness" is diminishing in crypto markets, leading to sizable liquidations. LiveSquawk's weekly newsletter, published every Friday, offers actionable insights across equities, energies, agriculture, metals, and other critical assets.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.